Patents by Inventor Michel Steiger

Michel Steiger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Topical composition
    Patent number: 8716340
    Abstract: The invention relates to beneficial topical pharmaceutical compositions comprising the diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: May 6, 2014
    Assignee: Novartis Consumer Health S.A.
    Inventor: Michel Steiger
  • TOPICAL COMPOSITION
    Publication number: 20140045942
    Abstract: The invention relates to beneficial topical pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.
    Type: Application
    Filed: October 14, 2013
    Publication date: February 13, 2014
    Applicant: Novartis AG
    Inventor: Michel STEIGER
  • Methods of treatment utilizing topical emulsion-gel composition comprising diclofenac sodium
    Patent number: 8557870
    Abstract: The invention relates to methods for treating burns or inflammation utilizing beneficial pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: October 15, 2013
    Assignee: Novartis Consumer Health S.A.
    Inventor: Michel Steiger
  • COMPOSITIONS FOR PERCUTANEOUS ADMINISTRATION
    Publication number: 20110165097
    Abstract: Compositions intended for the percutaneous administration of physiologically active agents, e.g. drugs or a veterinary agents, are disclosed. Sasd compositions are characterized by having an exeefenf long term efficacy due to their ability to form a long-lasting film on the skin.
    Type: Application
    Filed: September 9, 2009
    Publication date: July 7, 2011
    Applicant: Novartis AG
    Inventors: Fabienne Caillet-Bois, Isabelle Rault, Michel Steiger
  • TOPICAL COMPOSITION
    Publication number: 20100286268
    Abstract: The invention relates to beneficial topical pharmaceutical compositions comprising the diclofenac diethylammonium salt in unusually high amounts. Said compositions represent opaque emulsion-gels with unique properties such as high skin penetration, no irritation, high stability, complete dissolution of the active and high pain relief.
    Type: Application
    Filed: October 27, 2008
    Publication date: November 11, 2010
    Applicant: Novartis AG
    Inventors: Fabienne Caillett-Bois, Isabelle Rault, Michel Steiger
  • TOPICAL COMPOSITION
    Publication number: 20100234462
    Abstract: The invention relates to beneficial topical pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 16, 2010
    Applicant: Novartis AG
    Inventor: Michel STEIGER
  • Topical emulsion-gel composition comprising diclofenac sodium
    Patent number: 7732489
    Abstract: The invention relates to beneficial topical pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: June 8, 2010
    Assignee: Novartis AG
    Inventor: Michel Steiger
  • Drop Preparations Comprising Dimetindene
    Publication number: 20070287722
    Abstract: The invention relates to orally administered drops comprising the pharmaceutically active substance dimetindene, which drops are sorbitol-free and ethanol-free and characterized by special, very beneficial properties regarding physical and chemical stability, organoleptic properties as well as suitability for children.
    Type: Application
    Filed: August 10, 2005
    Publication date: December 13, 2007
    Inventors: Julien Rousset, Eric Turin, Michel Steiger
  • Topical composition comprising terbinaf ine adn hydrocortisone
    Publication number: 20070141089
    Abstract: The invention relates to topical pharmaceutical compositions comprising terbinafine and hydrocortisone. Said compositions exhibit beneficial antimycotic properties, especially against dermatophytes.
    Type: Application
    Filed: August 11, 2004
    Publication date: June 21, 2007
    Inventors: Catherine Larnier, Michel Steiger
  • Topical composition
    Publication number: 20050239894
    Abstract: The invention relates to beneficial topical pharmaceutical compositions comprising the diclofenac sodium salt in unusually low amounts. Said compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.
    Type: Application
    Filed: August 21, 2003
    Publication date: October 27, 2005
    Inventor: Michel Steiger
  • Topical composition
    Publication number: 20040101538
    Abstract: The invention relates to topical pharmaceutical compositions comprising an antifungal, e.g. terbinafine, and a second drug, e.g. diclofenac or indomethacin. Said compositions exhibit beneficial antimycotic properties, especially against dermatophytes.
    Type: Application
    Filed: September 23, 2003
    Publication date: May 27, 2004
    Inventors: Catherine Larnier, Michel Steiger
  • Pharmaceutical composition
    Patent number: 6121314
    Abstract: Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful delivery systems.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: September 19, 2000
    Assignee: Novartis AG
    Inventors: Friedrich Richter, Michel Steiger
  • Pharmaceutical composition
    Patent number: 6005001
    Abstract: Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful delivery systems.
    Type: Grant
    Filed: October 29, 1998
    Date of Patent: December 21, 1999
    Assignee: Novartis AG (formerly Sandoz AG)
    Inventors: Friedrich Richter, Michel Steiger
  • Pharmaceutical composition
    Patent number: 5856355
    Abstract: Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful delivery systems.
    Type: Grant
    Filed: July 22, 1997
    Date of Patent: January 5, 1999
    Assignee: Novartis Ag
    Inventors: Friedrich Richter, Michel Steiger
  • Pharmaceutical composition for topical applications
    Patent number: 5681849
    Abstract: Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful delivery systems.
    Type: Grant
    Filed: April 18, 1994
    Date of Patent: October 28, 1997
    Assignee: Novartis AG Ltd.
    Inventors: Friedrich Richter, Michel Steiger
  • Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration
    Patent number: 5393738
    Abstract: Polypeptide compositions for inter alia SMS are provided containing a monosaccharide/sugar alcohol and/or a polyoxyalkylene ether having enhanced resorption properties for oral or rectal administration.
    Type: Grant
    Filed: January 25, 1993
    Date of Patent: February 28, 1995
    Assignee: Sandoz, Ltd.
    Inventors: Jacky Vonderscher, Joachim Franz, Michel Steiger, Karl Hornung
  • Use of taurocholic acid and its salts as enhancers for calcitonin containing pharmaceutical compositions
    Patent number: 5149537
    Abstract: Suppositories comprising a suppository base, a calcitonin and taurocholic acid or a pharmaceutically acceptable salt thereof exhibit improved bioavailability and are well tolerated.
    Type: Grant
    Filed: November 14, 1991
    Date of Patent: September 22, 1992
    Assignee: Sandoz Ltd.
    Inventors: Moise Azria, Michel Steiger